News from the iDeAC Network

Affiliations

Latest

CODIAK: Harnessing the power of exosomes

Codiak BioSciences is pioneering exosome research and development to create an entirely new class of medicines, exosome therapeutics. There proprietary technology platform for exosome engineering and manufacturing allows precise therapeutic targeting, enabling them to develop therapies that may address a diverse array of diseases that are currently difficult or impossible to treat using existing methodologies.

Funding

Latest

First UK-wide study of brain complications in patients with COVID-19

Researchers from the University of Southampton are amongst a UK team of scientists to conduct the first nationwide surveillance study of the neurological complications of COVID-19. A study of 153 patients treated in UK hospitals during the acute phase of the COVID-19 pandemic describes a range of neurological and psychiatric complications that may be linked to the disease, including stroke and an altered mental state such as brain inflammation, psychosis and dementia-like symptoms.

Meetings

Latest

Integration of mouse and human studies for biomarker discovery in VCID

Donna M. Wilcock, PhD is the Sweeney-Nelms Professor in Alzheimer’s Disease Research at the Sanders-Brown Center on Aging and Professor in the Department of Physiology at the University of Kentucky. Dr. Wilcock was received her Bachelor’s degree in Pharmacology from Cardiff University. She obtained her Ph.D. at the University of South Florida, and completed postdoctoral training at Albert Einstein College of Medicine and Duke University. Dr. Wilcock’s research is focused on vascular cognitive impairment and dementia (VCID), a common cause of dementia and frequent co-morbidity with Alzheimer’s disease pathology. She is performing translational research on VCID, ranging from studying molecular mechanisms through identification of novel biomarkers in patients. She is primarily focused on inflammatory and angiogenic processes, as well as studying the influence VCID has on the progression and severity of Alzheimer's disease. Her work is funded by the National Institute on Aging and the National Institute on Neurological Disorders and Stroke.

Research

Latest

First UK-wide study of brain complications in patients with COVID-19

Researchers from the University of Southampton are amongst a UK team of scientists to conduct the first nationwide surveillance study of the neurological complications of COVID-19. A study of 153 patients treated in UK hospitals during the acute phase of the COVID-19 pandemic describes a range of neurological and psychiatric complications that may be linked to the disease, including stroke and an altered mental state such as brain inflammation, psychosis and dementia-like symptoms.